Biomedical Engineering Reference
In-Depth Information
[31] E. W. Kraegen, D. J. Chisholm and M. E. McNamara, Timing of insulin delivery with
meals,
Horm. Metab. Res
, 13, 365-367 (1981).
[32] G. D. Dimitriadis and J. E. Gerich, Importance of timing of preprandial subcutaneous
insulin administration in the management of diabetes mellitus,
Diabetes Care
, 6,
374-377 (1983).
[33] T. Blundell, G. Dodson, D. Hodgkin and D. Mercola, Insulin: The structure in the
crystal and its reflection in chemistry and biology,
Adv. Prot. Chem
., 26, 279-402
(1972).
[34] S. Ludvigsen, M. Roy, H. Thøgersen and N. C. Kaarsholm, High-resolution structure
of an engineered biologically potent insulin monomer, B16 Tyr—
>
His, as determined
by nuclear magnetic resonance spectroscopy,
Biochemistry
, 33, 7998-8006 (1994).
[35] H. B. Olsen, S. Ludvigsen and N. C. Kaarsholm, Solution structure of an engineered
insulin monomer at neutral pH,
Biochemistry
, 35, 8836-8845 (1996).
[36] H. Q. Xin, S. E. Shoelson, M. Kochoyan and M. A. Weiss, Receptor binding
redefined by a structural switch in a mutant human insulin,
Nature
, 354, 238-241
(1991).
[37] N. M. McKern, M. C. Lawrence, V. A. Streltsov, M. Z. Lou, T. E. Adams,
G. O. Lovrecz, T. C. Elleman, K. M. Richards, J. D. Bentley, P. A. Pilling,
P. A. Hoyne, K. A. Cartledge, T. M. Pham, J. L. Lewis, S. E. Sankovich,
V. Stoichevska, S. E. Da, C. P. Robinson, M. J. Frenkel, L. G. Sparrow, R. T. Fernley,
V. C. Epa and C. W. Ward, Structure of the insulin receptor ectodomain reveals a folded-
over conformation,
Nature
, 443, 218-221 (2006).
[38] C. W. Ward, M. C. Lawrence, V. A. Streltsov, T. E. Adams and N. M. McKern,
The insulin and EGF receptor structures: new insights into ligand-induced receptor
activation,
Trends Biochem. Sci
., 32, 129-137 (2007).
[39] R. Z. Luo, D. R. Beniac, A. Fernandes, C. C. Yip and F. P. Ottensmeyer, Quaternary
structure of the insulin-insulin receptor complex, Science (New York
,
N.Y
.)
, 285,
1077-1080 (1999).
[40] S. R. Hubbard, L. Wei, L. Ellis and W. A. Hendrickson, Crystal structure of the
tyrosine kinase domain of the human insulin receptor,
Nature
, 372, 746-754 (1994).
[41] C. Kristensen, T. Kjeldsen, F. C. Wiberg, L. Sch¨ ffer, M. Hach, S. Havelund, J. Bass,
D. F. Steiner and A. S. Andersen, Alanine scanning mutagenesis of insulin,
J. Biol.
Chem
., 272, 12978-12983 (1997).
[42] R. A. Pullen, D. G. Lindsay, S. P. Wood, I. J. Tickle, T. L. Blundell, A. Wollmer, G. Krail,
D. Brandenburg, H. Zahn, J. Gliemann and S. Gammeltoft, Receptor-binding region of
insulin,
Nature
, 259, 369-373 (1976).
[43] L. Sch¨ ffer, A model for insulin binding to the insulin receptor,
Eur. J. Biochem
., 221,
1127-1132 (1994).
[44] P. DeMeyts, A. R. Bainco and J. Roth, Site-site interactions among insulin receptors.
Characterization of the negative cooperativity,
J. Biol. Chem
., 251, 1877-1888 (1976).
[45] S. Huang and M. P. Czech, The GLUT4 glucose transporter,
Cell Metab
., 5, 237-252
(2007).
[46] I. M. A. Nooren and J. M. Thornton, Structural characterisation and functional signi-
ficance of transient protein-protein interactions,
J. Mol. Biol
., 325, 991-1018 (2003).
[47] M. J. Adams, T. L. Blundell, E. J. Dodson, G. G. Dodson, M. Vijayan, E. N. Baker,
M. M. Harding, D. C. Hodgkin, B. Rimmer and S. Sheat, Structure of rhombohedral
2 zinc insulin crystals,
Nature
, 224, 491-495 (1969).
Search WWH ::
Custom Search